Table 3– Main outcome variables at baseline and follow-up
Control groupExercise group
BaselineWeek 12BaselineWeek 12Week 24
Subjects n1211181815ƒ
ACQ0.90±0.150.99±0.161.30±0.190.72±0.10+0.72±0.17ƒ,##
ACQ with spirometry1.06±0.10#0.80±0.141.37±0.210.95±0.111.02±0.18
Perceived asthma control2.33±0.192.25±0.182.56±0.151.94±0.10§2.00±0.13ƒ,##
Mini-AQLQ5.79±0.155.90±0.175.01±0.215.84±0.176.11±0.21ƒ,##,¶¶
VO2,max2.66±0.272.77±0.292.63±0.202.88±0.213.00±0.27##
Submaximal VE/VO223.21±0.7323.64±0.8024.89±1.0823.78±0.74§24.35±0.90
Maximal VE/VO228.46±0.8828.65±1.3928.84±1.0227.44±0.7828.48±1.17
Submaximal DI0.42±0.030.42±0.020.45±0.020.48±0.03§0.54±0.03##
Maximal DI0.68±0.040.69±0.040.73±0.040.77±0.040.84±0.04
  • Data are presented as mean±se unless otherwise stated. ACQ: Asthma Control Questionnaire; mini-AQLQ: mini-Asthma Quality of Life Questionnaire; VO2,max: maximal oxygen uptake; VE: minute ventilation; VO2: oxygen uptake; DI: dyspnoea index. #: significant differences at baseline between control and exercise group; : n = 12 for paper measurements only; +: p<0.05 between groups from baseline to week 12; §: p<0.10 statistical trend from baseline to week 12; ƒ: n = 17 for paper measurements only; ##: p<0.05 within exercise group from weeks 12 to 24; ¶¶: p<0.05 within exercise group from weeks 12 to 24.